ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,541,870 | +30.3% | 716,462 | +68.6% | 0.08% | +29.3% |
| Q2 2023 | $19,599,438 | -64.8% | 424,874 | -69.4% | 0.06% | -66.3% |
| Q1 2023 | $55,613,126 | +65.0% | 1,386,861 | +90.6% | 0.17% | +49.6% |
| Q4 2022 | $33,713,739 | +132.2% | 727,687 | +107.5% | 0.12% | +98.3% |
| Q3 2022 | $14,522,000 | -11.0% | 350,687 | +28.2% | 0.06% | -15.9% |
| Q2 2022 | $16,318,000 | -29.4% | 273,515 | -14.1% | 0.07% | -25.0% |
| Q1 2022 | $23,129,000 | -35.4% | 318,497 | -25.2% | 0.09% | -35.7% |
| Q4 2021 | $35,812,000 | +16.7% | 425,874 | +25.1% | 0.14% | +5.9% |
| Q3 2021 | $30,698,000 | -54.5% | 340,374 | -51.9% | 0.14% | -55.4% |
| Q2 2021 | $67,441,000 | +395.2% | 707,300 | +491.4% | 0.30% | +373.4% |
| Q1 2021 | $13,618,000 | -17.8% | 119,600 | -0.1% | 0.06% | -21.0% |
| Q4 2020 | $16,570,000 | +230.2% | 119,700 | +1.9% | 0.08% | +211.5% |
| Q4 2019 | $5,018,000 | +110.1% | 117,496 | +110.5% | 0.03% | +73.3% |
| Q3 2019 | $2,388,000 | +9.7% | 55,816 | +62.9% | 0.02% | +36.4% |
| Q2 2019 | $2,176,000 | -71.2% | 34,263 | -80.3% | 0.01% | -70.3% |
| Q4 2018 | $7,552,000 | +182.6% | 173,700 | +396.3% | 0.04% | +236.4% |
| Q3 2018 | $2,672,000 | -42.1% | 35,000 | -41.7% | 0.01% | -38.9% |
| Q2 2018 | $4,612,000 | +29.2% | 60,000 | -14.3% | 0.02% | +20.0% |
| Q1 2018 | $3,569,000 | -17.6% | 70,000 | -25.1% | 0.02% | -21.1% |
| Q4 2017 | $4,332,000 | +62.7% | 93,400 | +86.8% | 0.02% | +58.3% |
| Q3 2017 | $2,663,000 | -34.0% | 50,000 | -23.1% | 0.01% | -47.8% |
| Q2 2017 | $4,037,000 | -25.5% | 65,000 | -18.8% | 0.02% | -23.3% |
| Q1 2017 | $5,422,000 | – | 80,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |